Private Investment vs. Public Funding in Therapeutic Development image

May 12, 2017 12:30 PM


  • Bhaven Sampat, PhD, Professor of Health Policy and Management, Columbia University Mailman School of Public Health

  • Terry McGuire, MS, MBA, Founding Partner, Polaris Partners

Learn more about the Health Policy and Bioethics Consortia. 

The Health Policy and Bioethics Consortia are hosted and organized by the Harvard Medical School Center for Bioethics and the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Harvard Program in Therapeutic Science. This monthly series convenes international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations. Support provided by the Oswald DeN. Cammann Fund at Harvard University. 


biotechnology   clinical research   health care finance   health law policy   health policy and bioethics consortia   pharmaceuticals   public health   regulation   research funding